ondansetron has been researched along with Chronic Hepatitis C in 2 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The 5-hydroxytryptamine receptor type 3 antagonist ondansetron had a significant positive effect on fatigue in CHC." | 9.11 | Effect of ondansetron, a 5-HT3 receptor antagonist, on fatigue in chronic hepatitis C: a randomised, double blind, placebo controlled study. ( Antoun, Z; Benzaken, S; Caroli-Bosc, FX; Cherikh, F; Demarquay, JF; Gelsi, E; Huet, PM; Piche, T; Rampal, P; Renou, C; Rigault, MC; Tran, A; Vanbiervliet, G, 2005) |
| "A woman with chronic hepatitis C and profound fatigue became symptomfree when treated long-term with ondansetron 4 mg twice daily." | 9.09 | Relief from profound fatigue associated with chronic liver disease by long-term ondansetron therapy. ( Jones, EA, 1999) |
| "The 5-hydroxytryptamine receptor type 3 antagonist ondansetron had a significant positive effect on fatigue in CHC." | 5.11 | Effect of ondansetron, a 5-HT3 receptor antagonist, on fatigue in chronic hepatitis C: a randomised, double blind, placebo controlled study. ( Antoun, Z; Benzaken, S; Caroli-Bosc, FX; Cherikh, F; Demarquay, JF; Gelsi, E; Huet, PM; Piche, T; Rampal, P; Renou, C; Rigault, MC; Tran, A; Vanbiervliet, G, 2005) |
| "A woman with chronic hepatitis C and profound fatigue became symptomfree when treated long-term with ondansetron 4 mg twice daily." | 5.09 | Relief from profound fatigue associated with chronic liver disease by long-term ondansetron therapy. ( Jones, EA, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Piche, T | 1 |
| Vanbiervliet, G | 1 |
| Cherikh, F | 1 |
| Antoun, Z | 1 |
| Huet, PM | 1 |
| Gelsi, E | 1 |
| Demarquay, JF | 1 |
| Caroli-Bosc, FX | 1 |
| Benzaken, S | 1 |
| Rigault, MC | 1 |
| Renou, C | 1 |
| Rampal, P | 1 |
| Tran, A | 1 |
| Jones, EA | 1 |
2 trials available for ondansetron and Chronic Hepatitis C
| Article | Year |
|---|---|
Effect of ondansetron, a 5-HT3 receptor antagonist, on fatigue in chronic hepatitis C: a randomised, double blind, placebo controlled study.
Topics: Administration, Oral; Adolescent; Adult; Aged; Depression; Double-Blind Method; Fatigue; Female; Hep | 2005 |
Relief from profound fatigue associated with chronic liver disease by long-term ondansetron therapy.
Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Fatigue; | 1999 |